Skip to content
healthcare.dev

Theophylline

NDC 46708-026, Theophylline, tablet, extended release, from Alembic Pharmaceuticals Limited.

Product NDC
46708-026
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090430
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • THEOPHYLLINE ANHYDROUS450 mg/1

Pharmacologic classes

Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
46708-026-304670800263030 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-026-30)
46708-026-3146708002631100 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-026-31)
46708-026-7146708002671500 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-026-71)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/31f3c720-1597-4d43-9296-33017b90b15f

Use it

Look up 46708-026 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.